Download IXRS Resources

Talk to our
IXRS experts

+91 999 888 5186

Call to Our Experts

IXRS Overview:

Platform Type: Web-based SaaS
Primary Use: Randomization & Drug/Device Accountability

IXRS is an interactive web response system (IWRS) designed by Landmark Research, which is offered as a software as a service (SaaS) for its clients to perform randomization and drug/device accountability in their clinical studies.

IXRS is a web-based platform that allows the users to perform the following functions:

EDC System Features

Secure • Reliable •
Compliant

Core Functions

IXRS provides comprehensive randomization and drug/device accountability capabilities for clinical trials with advanced tracking and management features.

  • Subject Randomization

  • Drug/Device Tracking

  • Inventory Management

  • Emergency Unblinding

  • Randomization
    &
    Management

    IXRS enables users to randomize subjects into different treatment groups based on study design and criteria. It supports various randomization methods including simple, stratified, block, and adaptive randomization, with capabilities for re-randomization, unblinding, and emergency unblinding.

  • Drug/Device
    Accountability

    IXRS enables users to track and manage inventory and distribution of study drugs/devices from manufacturer to site to subject. It supports various types including tablets, capsules, injections, implants, and devices, with dispensing, return, reconciliation, and destruction capabilities.

  • Advanced Tracking
    & Compliance

    IXRS provides comprehensive tracking of expiry dates, batch numbers, and manages randomization codes and lists. It ensures proper accountability and compliance throughout the clinical trial process with advanced inventory management features.

Talk to our IXRS experts

Speak with our IXRS specialists to learn more about our interactive web response system, request a demo, or get help with implementation. Our dedicated team is ready to assist you with all your clinical trial randomization and drug/device accountability needs.

Landmark CRO
Go Back Top